3. November 2020 - NanoMab and gate startup OncoBeta outline the pathway to a Strategic Alliance and Supply Agreement, focused on the secure supply of Rhenium-188 for NanoMab’s range of Therapeutic Radiopharmaceuticals NanoMab Technology ... mehr erfahren

News
24. September 2020 - Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer of the gate-startup to be produced in Australia OncoBeta® GmbH, a commercial stage medical device company specialized in innovative epidermal radioisotope ... mehr erfahren
9. Dezember 2019 - OncoBeta® has recently been presented with the CV Magazine’s Corporate Excellence Award for the Most Compassionate Skin Cancer Therapy Provider in 2019. The Medical Device Company specialized in innovative epidermal radioisotope ... mehr erfahren